| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/01/2006 | US20060115829 An isolated nucleic acid sequence encoding a DNA methyltransferase-3B variant having aseleted amino acid sequence; screening for enzyme inhibitor compounds to be used as anticarcinogenic agents for, particularly, lung cancer and, more particularly, non-small cell lung cancer |
| 06/01/2006 | US20060115816 Splice variant cannabinoid receptor (cb1b) |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115811 Cytochrome p450ra1-2 and related proteins |
| 06/01/2006 | US20060115805 Gelatine-based materials as swabs |
| 06/01/2006 | US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115484 Nucleic acid for modulating apoptosis |
| 06/01/2006 | US20060115483 Receptor polypeptide and polynucleotide encoding polypeptide; anticancer agents; viricides; multiple sclerosis; antiarthritic agents; cardiovascular disorders; osteoporosis |
| 06/01/2006 | US20060115479 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 06/01/2006 | US20060115477 Neuropilin-1 inhibitors |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115451 Modified cytokines for use in cancer therapy |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589471A1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | CA2589164A1 Production of proteins |
| 06/01/2006 | CA2589151A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | CA2588039A1 Biomaterial which can successively carry out a solution/gel transition then a gel/solution transition |
| 06/01/2006 | CA2586128A1 Enzymatic reactions in the presence of keto acids |
| 05/31/2006 | EP1662258A1 A substrate free in vitro protein kinase assay |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661913A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 05/31/2006 | EP1661909A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 05/31/2006 | EP1660686A2 Hpv cd8+ t-cell epitopes |
| 05/31/2006 | EP1660661A2 Methods of protein production in yeast |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660646A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660533A2 Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660128A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1470229B1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 05/31/2006 | EP1322284B1 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP1045027B1 Novel gene having reverse transcriptase motif |
| 05/31/2006 | EP1025235B1 Expression system |
| 05/31/2006 | EP1000151B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 05/31/2006 | EP0974671B1 Method for diagnosing bone dysbolism |
| 05/31/2006 | EP0915156B1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1778932A Improvement for exogenous protein accumulation in transgene plant |
| 05/31/2006 | CN1778930A Fusion gene of provocative organ anti-Coccidium tenellum infection and its coding protein and use thereof |
| 05/31/2006 | CN1778929A Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 05/31/2006 | CN1778927A Coding nucleotide sequence of cupular virus capsid protein with codon optimization and use thereof |
| 05/31/2006 | CN1778923A Gene sequence for human granulocyte macrophage colony stimulus factor with specific expression |
| 05/31/2006 | CN1778920A Antibiotic peptide gene and its yeast expression carrier |
| 05/31/2006 | CN1778916A Polypeptide with Beta-lactamase inhibiting activity and its coded DNA |
| 05/31/2006 | CN1778914A Expression of soluble TRAIL protein |
| 05/31/2006 | CN1778908A Production of proteinase from gene recombinant pichia |
| 05/31/2006 | CN1257985C Method for detection of susceptibility mutations for ototoxic deafness |
| 05/31/2006 | CN1257984C Method for preparing rice protein peptide and its use |
| 05/31/2006 | CN1257983C Egg small peptide preparation |
| 05/30/2006 | US7054384 Power amplifier sharing in a wireless communication system with transmit diversity |
| 05/30/2006 | US7053268 Promoter |
| 05/30/2006 | US7053266 Chimeric cry1E δendotoxin and methods of controlling insects |
| 05/30/2006 | US7053265 Nucleotide sequences for use as tools in the expression of heterologous gene in plants |
| 05/30/2006 | US7053262 Activation; transgenic rodent; genetic engineering |
| 05/30/2006 | US7053204 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants |
| 05/30/2006 | US7053189 Human dopamine receptor and its uses |
| 05/30/2006 | US7053187 Sperm-specific monoclonal antibody, mAbC |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053184 Expression vector coding polypeptide with thrombin proteolytic sequences; for use in evaluating ligand binding and signal transduction |
| 05/30/2006 | US7053181 Canine and feline B7-2 proteins, compositions and uses thereof |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7052908 Androgen receptor coactivators |
| 05/30/2006 | US7052900 Saccharomyces cerevisiae yeast strain with functional expression of a Glut transporter |
| 05/30/2006 | US7052892 For preventing, ameliorating, disorders or diseases including cancer, peripheral and central nervous system disorders, genitourinary disorders, cardiovascular disorders, and Chronic obstructive pulmonary (or airways) disease (COPD) |
| 05/30/2006 | US7052874 Killing microorganism; measurement, calibration antibiotic resistance |
| 05/30/2006 | US7052873 Natural human antibody |
| 05/30/2006 | US7052872 Bi-specific antibodies for pre-targeting diagnosis and therapy |
| 05/30/2006 | US7052870 nucleotide sequences and complements that code mammalian targets of ripamycin (mTOR) and rapamycin insensitive companion of mammalian targets of ripamycin (rictor), used as screening targets for the identification and drugs which modulate the activity of enzymes |
| 05/30/2006 | US7052869 Obtaining a consensus protein from a group of amino acid sequences of a defined protein family |
| 05/30/2006 | US7052868 Human coagulation factor VII polypeptides |
| 05/30/2006 | US7052867 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052687 Human recombinant beta-interferon with improved solubility |
| 05/30/2006 | US7052675 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2005311C Prototype felv isolates for use in disease models and vaccines |
| 05/26/2006 | WO2006055927A2 Pathogenic gene and protein associated with paroxysmal dyskinesia and epilepsy |